He GW.  Yang CQ.  Vasorelaxant effect of the phosphodiesterase-inhibitor milrinone in the human radial artery used as coronary bypass graft.  Journal of Thoracic & Cardiovascular Surgery.  119(5):1039-45, 2000.
Siostrzonek P.  Koreny M.  Delle-Karth G.  Haumer M.  Koller-Strametz J.  Heinz G.  Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.  Acta Anaesthesiologica Scandinavica.  44(4):403-9, 2000.
Lowes BD.  Simon MA.  Tsvetkova TO.  Bristow MR.  Inotropes in the beta-blocker era.  Clinical Cardiology.  23(3 Suppl):III11-6, 2000.
Iribe G.  Yamada H.  Matsunaga A.  Yoshimura N.  Effects of the phosphodiesterase III inhibitors olprinone, milrinone, and amrinone on hepatosplanchnic oxygen metabolism.  Critical Care Medicine.  28(3):743-8, 2000.
Lobato EB.  Urdaneta F.  Martin TD.  Gravenstein N.  Effects of milrinone versus epinephrine on grafted internal mammary artery flow after cardiopulmonary bypass.  Journal of Cardiothoracic & Vascular Anesthesia.  14(1):9-11, 2000.
Solina A.  Papp D.  Ginsberg S.  Krause T.  Grubb W.  Scholz P.  Pena LL.  Cody R.  A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients.  Journal of Cardiothoracic & Vascular Anesthesia.  14(1):12-7, 2000.
Gold JA.  Cullinane S.  Chen J.  Oz MC.  Oliver JA.  Landry DW.  Vasopressin as an alternative to norepinephrine in the treatment of milrinone-induced hypotension.  Critical Care Medicine.  28(1):249-52, 2000.
Teerlink JR.  Jalaluddin M.  Anderson S.  Kukin ML.  Eichhorn EJ.  Francis G.  Packer M.  Massie BM.  Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death.  Circulation.  101(1):40-6, 2000.
Hayashida N.  Tomoeda H.  Oda T.  Tayama E.  Chihara S.  Kawara T.  Aoyagi S.  Inhibitory effect of milrinone on cytokine production after cardiopulmonary bypass.  Annals of Thoracic Surgery.  68(5):1661-7, 1999.
Bardou M.  Cortijo J.  Loustalot C.  Taylor S.  Perales-Marin A.  Mercier FJ.  Dumas M.  Deneux-Tharaux C.  Frydman R.  Morcillo EJ.  Advenier C.  Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium.  Naunyn-Schmiedebergs Archives of Pharmacology.  360(4):457-63, 1999.
Rosenzweig EB.  Starc TJ.  Chen JM.  Cullinane S.  Timchak DM.  Gersony WM.  Landry DW.  Galantowicz ME.  Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery.  Circulation.  100(19 Suppl):II182-6, 1999.
Heinz G. Geppert A. Delle Karth G. Reinelt P. Gschwandtner ME. Neunteufl T. Zauner C. Frossard M. Siostrzonek P. IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure. Intensive Care Medicine. 1999;25(6):620-4.
Hatzizacharias A. Makris T. Krespi P. Triposkiadis F. Voyatzi P. Dalianis N. Kyriakidis M. Intermittent milrinone effect on long-term hemodynamic profile in patients with severe congestive heart failure [see comments]. American Heart Journal. 1999;138(2 Pt 1):241-6.
Pamboukian SV. Carere RG. Webb JG. Cook RC. D'yachkova Y. Abel JG. Ignaszewski AP. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.  Journal of Heart & Lung Transplantation. 1999;18(4):367-71.
Bailey JM. Miller BE. Lu W. Tosone SR. Kanter KR. Tam VK. The pharmacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology. 1999;90(4):1012-8.
Butterworth JF 4th. Legault C. Royster RL. Hammon JW Jr. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesthesia & Analgesia. 1998;86(3):461-7.
Huraux C. Makita T. Montes F. Szlam F. Levy JH. A comparative evaluation of the effects of multiple vasodilators on human internal mammary artery. Anesthesiology. 1998;88(6):1654-9.
Rathmell JP. Prielipp RC. Butterworth JF. Williams E. Villamaria F. Testa L. Viscomi C. Ittleman FP. Baisden CE. Royster RL. A multicenter, randomized, blind comparison of amrinone with milrinone after elective cardiac surgery. Anesthesia & Analgesia. 1998;86(4):683-90.
Mollhoff T. Loick HM. Van Aken H. Schmidt C. Rolf N. Tjan TD. Asfour B. Berendes E. Milrinone modulates endotoxemia, systemic inflammation, and subsequent acute phase response after cardiopulmonary bypass (CPB).  Anesthesiology. 1999;90(1):72-80.
Kirsten R. Nelson K. Kirsten D. Heintz B. Clinical pharmacokinetics of vasodilators. Part II. Clinical Pharmacokinetics. 1998;35(1):9-36.
Lindsay CA. Barton P. Lawless S. Kitchen L. Zorka A. Garcia J. Kouatli A. Giroir B. Pharmacokinetics and pharmacodynamics of milrinone lactate in pediatric patients with septic shock. Journal of Pediatrics. 1998;132(2):329-34.
Ramamoorthy C. Anderson GD. Williams GD. Lynn AM. Pharmacokinetics and side effects of milrinone in infants and children after open heart surgery. Anesthesia & Analgesia. 1998;6(2):283-9.
Mehra MR. Ventura HO. Kapoor C. Stapleton DD. Zimmerman D. Smart FW. Safety and clinical utility of long-term intravenous milrinone in advanced heart failure. American Journal of Cardiology. 1997;80(1):61-4.
Kikura M. Levy JH. Michelsen LG. Shanewise JS. Bailey JM. Sadel SM. Szlam F.  The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass. Anesthesia & Analgesia. 1997;85(1):16-22.
Doolan LA. Jones EF. Kalman J. Buxton BF. Tonkin AM. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. Journal of Cardiothoracic & Vascular Anesthesia. 1997;11(1):37-41.
Liu JJ. Doolan LA. Xie B. Chen JR. Buxton BF. Direct vasodilator effect of milrinone, an inotropic drug, on arterial coronary bypass grafts. FANZCA  Journal of Thoracic & Cardiovascular Surgery. 1997;113(1):108-13.
Khajavi K. Ayzman I. Shearer D. Jones SC. Levy JH. Prayson RA. Skibinski CI. Hahn JF. Chyatte D. Prevention of chronic cerebral vasospasm in dogs with milrinone. Neurosurgery. 1997;40(2):354-62; discussion 362-3.
Karlsberg RP. DeWood MA. DeMaria AN. Berk MR. Lasher KP. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction.  Milrinone-Dobutamine Study Group. Clinical Cardiology. 1996;19(1):21-30.
Prielipp RC. MacGregor DA. Butterworth JF 4th. Meredith JW. Levy JH. Wood KE. Coursin DB.  Pharmacodynamics and pharmacokinetics of milrinone administration to increase oxygen delivery in critically ill patients. Chest. 1996;109(5):1291-301.
Salmenpera M. Levy JH. The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. Anesthesia & Analgesia. 1996;82(5):954-7.
He GW. Yang CO. Gately H. Furnary A. Swanson J. Ahmad A. Floten S. Wood J. Starr A. Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries. British Journal of Clinical Pharmacology. 1996;41(2):101-7.
Marius-Nunez AL. Heaney L. Fernandez RN. Clark WA. Ranganini A. Silber E. Denes P. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. American Heart Journal. 1996;132(4):805-8.
Seino Y. Momomura S. Takano T. Hayakawa H. Katoh K. Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators. Critical Care Medicine. 1996;24(9):1490-7.
Vroom MB. Pfaffendorf M. van Wezel HB. van Zwieten PA. Effect of phosphodiesterase inhibitors on human arteries in vitro. British Journal of Anaesthesia. 1996;76(1):122-9.
Butterworth JF 4th. Hines RL. Royster RL. James RL. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery  Anesthesia & Analgesia. 1995;81(4):783-92.
Kikura M. Lee MK. Safon RA. Bailey JM. Levy JH. The effects of milrinone on platelets in patients undergoing cardiac surgery. Anesthesia & Analgesia. 1995;81(1):44-8.
Bailey JM. Levy JH. Kikura M. Szlam F. Hug CC Jr. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery. Anesthesiology. 1994;81(3):616-22.